Hosted on MSN10mon
A decade after sparking the Seaport’s boom, Vertex is considering leaving Fan Pier
the buildings where it has operated since relocating ... glass towers that today has become an extension of downtown Boston. Before Vertex showed up, that vision was a long way from reality.
Zoning commission rules new Boston buildings will be required to meet ‘net zero’ standards
The Boston Zoning Commission voted to approve a new zoning standard requiring new buildings to meet net zero carbon emissions ...
Top Vertex exec to retire after more than 12 years with company
Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue ...
South Boston Online5d
Important New VERTEX Painkiller Is Approved
By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...
CBS Boston on MSN18d
Boston City Hall, once named 4th ugliest building in the world, is now a historical landmark
Boston City Hall, known for its brutalist architecture, is now an official historical landmark despite once being named the ...
FDA approves new type of non-addictive painkiller from Boston drug company
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.
The Boston Globe11d
At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...
WBUR12d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new ...
Business Wire1mon
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore
Zai Lab will leverage its local expertise and commercial footprint to accelerate development of povetacicept and bring the medicine to eligible patients in the region if approved - BOSTON ...